Kevin Bell Quoted in Wall Street Journal Article on Inaccurate Labeling of Melatonin Gummies

In an April 25, 2023, article in The Wall Street Journal calling to question melatonin gummy labels and FDA regulation, AGG Dietary Supplements industry team co-chair Kevin Bell provided insight into FDA’s enforcement of dietary supplements.

The article suggested that people who take melatonin gummies are getting more melatonin than their labels disclose, with one brand’s product “containing nearly 350% more,” according to an analysis published in the Journal of the American Medical Association.

While some dietary supplement companies argue that their products are safe, some supplement industry representatives, like Kevin who represents the Natural Products Association, are pushing for Congress and FDA to do more to enforce current regulations and laws.

To read the full article, please click here.